Argentine-Uruguayan, Eolo Pharma, prescribed US$2.7 million injection in Series A round

Jan 08, 2020

Contxto – After having piqued the interest of various health-conscious investors, Eolo Pharma—a clinical research startup from both Uruguay and Argentina—received an investment of US$2.7 million.

The Series A round was led by VC (venture capital) funds, CITES and Ficus Capital, adding financial weight to the academic and institutional heft the company already had behind it. The healthtech includes global and […]

The post about "Argentine-Uruguayan, Eolo Pharma, prescribed US$2.7 million injection in Series A round" appeared first in Contxto website.

To engage in latest trends, developments and opportunities in health and wellness across Australia and Latin America, join our community at Health and Well-Being Group.

Not yet a member? Get connected and be inspired by more incredible Latin American and Australian professionals. Join the growing Somos21 Community.

Connections are growing between Australia and LatinAmerica. With Somos21 this innovative #onlineplatform allows you to find, connect, and collaborate at a global level who share the same background or interest in Latin America and Australia. This give people the opportunity to meet in person and build their personal and professional networks at a local level. 

Have you downloaded the Somos21 app to your phone yet? Take your networking to the next level! 

Download our smart phone app on iOS and Android now!!!\


Other news